Hyperthermia Cancer Treatment Market Analysis By Device (Infrared Devices, Ultrasound, Microwave Devices), By Treatment Method (Loco-regional Method, External & Interstitial), By Application, By End User, By Region - Global Insights 2021 to 2031

Table of Content

1. Preface

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Hyperthermia Cancer Treatment Market Forecast

    4.4. Global Hyperthermia Cancer Treatment Market Outlook

5. Market Outlook

    5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.2. Epidemiology of Cancer Globally/Country

    5.3. Reimbursement Scenario 

    5.4. Regulatory Scenario 

    5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia 

6. Global Hyperthermia Cancer Treatment Market Analysis, by Device

    6.1. Introduction 

    6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device

        6.3.1. Infrared Hyperthermia Devices

        6.3.2. Ultrasound Hyperthermia Devices

        6.3.3. Microwave Hyperthermia Devices

        6.3.4. Others

    6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device

7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

    7.1. Introduction 

    7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        7.3.1. Locoregional

            7.3.1.1. External & Interstitial

            7.3.1.2. Intraluminal or Endocavitary Methods

            7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            7.3.1.4. Deep Tissue & Regional Perfusion

        7.3.2. Whole-body

    7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

8. Global Hyperthermia Cancer Treatment Market Analysis, by Application

    8.1. Introduction 

    8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application

        8.3.1. Breast Cancer

        8.3.2. Liver Cancer

        8.3.3. Soft Tissue Sarcoma

        8.3.4. Head & Neck Tumors

        8.3.5. Prostate Cancer

        8.3.6. Others

    8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application

9. Global Hyperthermia Cancer Treatment Market Analysis, by End User

    9.1. Introduction 

    9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End User

        9.3.1. Hospitals & Specialty Clinics

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Others 

    9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End User

10. Global Hyperthermia Cancer Treatment Market Analysis, by Region

    10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country

    10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region

    10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

11. North America Hyperthermia Cancer Treatment Market Analysis

    11.1. North America Hyperthermia Cancer Treatment Market Overview

    11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country

    11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device

        11.5.1. Infrared Hyperthermia Devices

        11.5.2. Ultrasound Hyperthermia Devices

        11.5.3. Microwave Hyperthermia Devices

        11.5.4. Others

    11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        11.7.1. Locoregional

            11.7.1.1. External & Interstitial

            11.7.1.2. Intraluminal or Endocavitary Methods

            11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            11.7.1.4. Deep Tissue & Regional Perfusion

        11.7.2. Whole-body

    11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application

        11.9.1. Breast Cancer

        11.9.2. Liver Cancer

        11.9.3. Soft Tissue Sarcoma

        11.9.4. Head & Neck Tumors

        11.9.5. Prostate Cancer

        11.9.6. Others

    11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End User

        11.11.1. Hospitals & Specialty Clinics

        11.11.2. Ambulatory Surgical Centers

        11.11.3. Others 

12. Europe Hyperthermia Cancer Treatment Market Analysis

    12.1. Europe Hyperthermia Cancer Treatment Market Overview

    12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. France

        12.3.3. U.K.

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device

        12.5.1. Infrared Hyperthermia Devices

        12.5.2. Ultrasound Hyperthermia Devices

        12.5.3. Microwave Hyperthermia Devices

        12.5.4. Others

    12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        12.7.1. Locoregional

            12.7.1.1. External & Interstitial

            12.7.1.2. Intraluminal or Endocavitary Methods

            12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            12.7.1.4. Deep Tissue & Regional Perfusion

        12.7.2. Whole-body

    12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application

        12.9.1. Breast Cancer

        12.9.2. Liver Cancer

        12.9.3. Soft Tissue Sarcoma

        12.9.4. Head & Neck Tumors

        12.9.5. Prostate Cancer

        12.9.6. Others

    12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End User

        12.11.1. Hospitals & Specialty Clinics

        12.11.2. Ambulatory Surgical Centers

        12.11.3. Others 

13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis

    13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview

    13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        13.3.1. Japan

        13.3.2. China

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device

        13.5.1. Infrared Hyperthermia Devices

        13.5.2. Ultrasound Hyperthermia Devices

        13.5.3. Microwave Hyperthermia Devices

        13.5.4. Others

    13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        13.7.1. Locoregional

            13.7.1.1. External & Interstitial

            13.7.1.2. Intraluminal or Endocavitary Methods

            13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            13.7.1.4. Deep Tissue & Regional Perfusion

        13.7.2. Whole-body

    13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application

        13.9.1. Breast Cancer

        13.9.2. Liver Cancer

        13.9.3. Soft Tissue Sarcoma

        13.9.4. Head & Neck Tumors

        13.9.5. Prostate Cancer

        13.9.6. Others

    13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End User

        13.11.1. Hospitals & Specialty Clinics

        13.11.2. Ambulatory Surgical Centers

        13.11.3. Others 

14. Latin America Hyperthermia Cancer Treatment Market Analysis

    14.1. Latin America Hyperthermia Cancer Treatment Market Overview

    14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device

        14.5.1. Infrared Hyperthermia Devices

        14.5.2. Ultrasound Hyperthermia Devices

        14.5.3. Microwave Hyperthermia Devices

        14.5.4. Others

    14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        14.7.1. Locoregional

            14.7.1.1. External & Interstitial

            14.7.1.2. Intraluminal or Endocavitary Methods

            14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            14.7.1.4. Deep Tissue & Regional Perfusion

        14.7.2. Whole-body

    14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application

        14.9.1. Breast Cancer

        14.9.2. Liver Cancer

        14.9.3. Soft Tissue Sarcoma

        14.9.4. Head & Neck Tumors

        14.9.5. Prostate Cancer

        14.9.6. Others

    14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End User

        14.11.1. Hospitals & Specialty Clinics

        14.11.2. Ambulatory Surgical Centers

        14.11.3. Others 

15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis

    15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview

    15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device

    15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device

        15.5.1. Infrared Hyperthermia Devices

        15.5.2. Ultrasound Hyperthermia Devices

        15.5.3. Microwave Hyperthermia Devices

        15.5.4. Others

    15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        15.7.1. Locoregional

            15.7.1.1. External & Interstitial

            15.7.1.2. Intraluminal or Endocavitary Methods

            15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            15.7.1.4. Deep Tissue & Regional Perfusion

        15.7.2. Whole-body

    15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application

        15.9.1. Breast Cancer

        15.9.2. Liver Cancer

        15.9.3. Soft Tissue Sarcoma

        15.9.4. Head & Neck Tumors

        15.9.5. Prostate Cancer

        15.9.6. Others

    15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End User

    15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End User

        15.11.1. Hospitals & Specialty Clinics

        15.11.2. Ambulatory Surgical Centers

        15.11.3. Others

16. Competition Landscape

    16.1. Competition Matrix 

    16.2. Company Profiles

        16.2.1. Pyrexar Medical 

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Product Portfolio

            16.2.1.3. SWOT Analysis

            16.2.1.4. Strategic Overview

        16.2.2. Celsius42 GmbH 

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Product Portfolio

            16.2.2.3. SWOT Analysis

            16.2.2.4. Strategic Overview

        16.2.3. Hydrosun GmbH 

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Product Portfolio

            16.2.3.3. SWOT Analysis

            16.2.3.4. Strategic Overview

        16.2.4. OncothermKft

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Product Portfolio

            16.2.4.3. SWOT Analysis

            16.2.4.4. Strategic Overview

        16.2.5. AndromedicS.r.l. 

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Product Portfolio

            16.2.5.3. SWOT Analysis

            16.2.5.4. Strategic Overview

        16.2.6. Yamamoto Vinita Co., Ltd. 

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Product Portfolio

            16.2.6.3. SWOT Analysis

            16.2.6.4. Strategic Overview

        16.2.7. Chongqing Haifu Medical Technology Co., Ltd 

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Product Portfolio

            16.2.7.3. SWOT Analysis

            16.2.7.4. Strategic Overview

        16.2.8. InnoMedicus Ltd. 

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Product Portfolio

            16.2.8.3. SWOT Analysis

            16.2.8.4. Strategic Overview

        16.2.9. Gamida

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Product Portfolio

            16.2.9.3. SWOT Analysis

            16.2.9.4. Strategic Overview

        16.2.10. RanD. 

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Product Portfolio

            16.2.10.3. SWOT Analysis

            16.2.10.4. Strategic Overview

List of Tables

Table 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031

Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2021-2031

Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2021-2031

Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2021-2031

Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031

Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031

Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031

Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2021-2031

Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031

Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031

Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2021-2031

Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device, 2021-2031

Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2021-2031

Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2021-2031

Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2021-2031

Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End User, 2021-2031

List of Figures

Figure 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, 2021-2031

Figure 02: Global Hyperthermia Cancer Treatment Market Value Share, by Device, 2020

Figure 03: Global Hyperthermia Cancer Treatment Market Value Share, by Treatment Method, 2020

Figure 04: Global Hyperthermia Cancer Treatment Market Value Share, by Application, 2020

Figure 05: Global Hyperthermia Cancer Treatment Market Value Share, by End User, 2020

Figure 06: Global Hyperthermia Cancer Treatment Market Value Share, by Region, 2020

Figure 07: Global New Cancer Cases & Deaths, 2017 

Figure 08: Incidence of Breast Cancer, by Country

Figure 09: Prevalence of Breast Cancer, by Country

Figure 10: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

Figure 11: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 12: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Infrared Hyperthermia Devices, 2021-2031

Figure 13: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ultrasound Hyperthermia Devices, 2021-2031

Figure 14: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Microwave Hyperthermia Devices, 2021-2031

Figure 15: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2021-2031

Figure 16: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 17: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031

Figure 18: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Locoregional, 2021-2031

Figure 19: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Whole-Body, 2021-2031

Figure 20: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 21: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 22: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Breast Cancer, 2021-2031

Figure 23: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Liver Cancer, 2021-2031

Figure 24: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Soft Tissue Sarcoma, 2021-2031

Figure 25: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Head & Neck Tumors, 2021-2031

Figure 26: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Prostate Cancer, 2021-2031

Figure 27: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2021-2031

Figure 28: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 29: Global Hyperthermia Cancer Treatment Market Attractiveness, by End User, 2021–2031

Figure 30: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Hospitals & Specialty Clinics, 2021-2031

Figure 31: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2021-2031

Figure 32: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Standalone Devices, 2021-2031

Figure 33: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Region, 2021 and 2031

Figure 34: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Region

Figure 35: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031

Figure 36: North America Hyperthermia Cancer Treatment Market Value Share (%), by Country, 2021 and 2031

Figure 37: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country, 2021–2031

Figure 38: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

 Figure 39: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 40: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 41: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2031

Figure 42: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 43: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 44: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 45: North America Hyperthermia Cancer Treatment Market Attractiveness, by End User, 2021–2031

Figure 46: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031

Figure 47: Europe Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 48: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 49: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

Figure 50: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 51: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 52: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031

Figure 53: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 54: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 55: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 56: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031

Figure 57: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031

Figure 58: Asia Pacific Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 59: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 60: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

Figure 61: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 62: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 63: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031

Figure 64: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 65: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 66: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 67: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031

Figure 68: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031

Figure 69: Latin America Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 70: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 71: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

Figure 72: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 73: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 74: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031

Figure 75: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 76: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 77: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 78: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031

Figure 79: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2021-2031

Figure 80: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 81: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 82: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Device, 2021 and 2031

Figure 83: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device, 2021–2031

Figure 84: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2021 and 2031

Figure 85: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2021–2031

Figure 86: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2021 and 2031

Figure 87: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2021–2031

Figure 88: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by End User, 2021 and 2031

Figure 89: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End User, 2021–2031

Hyperthermia Cancer Treatment Market - Scope of Report

A recent study by Fact.MR on the hyperthermia cancer treatment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering hyperthermia cancer treatment.

The study also provides the dynamics that are responsible for influencing the future status of the hyperthermia cancer treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the hyperthermia cancer treatment space, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of hyperthermia cancer treatment solutions across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of hyperthermia cancer treatment solutions during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

• Which are the most lucrative markets for hyperthermia cancer treatment?
• Which factors will impact the growth of the market over the coming years?
• How will changing trends impact the strategies of market players?
• How can market players capture the low-hanging opportunities across regions?
• Which companies are leading the hyperthermia cancer treatment industry?
• What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each market segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for hyperthermia cancer treatment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global hyperthermia cancer treatment market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for hyperthermia cancer treatment has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of hyperthermia cancer treatment solutions, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering hyperthermia cancer treatment solutions has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the hyperthermia cancer treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.